ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
暂无分享，去创建一个
P. Seidel | M. Boerries | D. von Elverfeldt | M. Follo | I. Frew | C. Schell | R. Lindemann | F. Zenke | W. Reichardt | Patrick Metzger | F. Neumann | Rouven Hoefflin | Mojca Adlesic | Asin Peighambari | J. Albers | Anne Rubarth | Hsin Huang | Kyra Zodel | Yannick Federkiel | C. Witt | David J Hoffmann